CAP—advancing the evaluation of preclinical Alzheimer disease treatments

If we are to find treatments to postpone, reduce the risk of, or completely prevent the clinical onset of Alzheimer disease (AD), we need faster methods to evaluate promising preclinical AD treatments, new ways to work together in support of common goals, and a determination to expedite the initiati...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nat Rev Neurol
Hlavní autoři: Reiman, Eric M., Langbaum, Jessica B., Tariot, Pierre N., Lopera, Francisco, Bateman, Randall J., Morris, John C., Sperling, Reisa A., Aisen, Paul S., Roses, Allen D., Welsh-Bohmer, Kathleen A., Carrillo, Maria C., Weninger, Stacie
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847536/
https://ncbi.nlm.nih.gov/pubmed/26416539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrneurol.2015.177
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky